Search clinical trials for: Mirabegron, Propevirine, Solifenacin
Total 307 results
-
Mansoura UniversityRecruiting
-
Astellas Pharma IncCompleted
-
Astellas Pharma Singapore Pte. Ltd.CompletedOveractive Bladder (OAB)Korea, Republic of, Australia
-
Astellas Pharma Singapore Pte. Ltd.CompletedOveractive Bladder (OAB)Korea, Republic of, Taiwan
-
Astellas Pharma Europe Ltd.CompletedUrologic Diseases | Urinary Bladder Diseases | Urinary Bladder OveractiveUnited States, Armenia, Australia, Austria, Belgium, Canada, Czechia, Denmark, Finland, France, Georgia, Germany, Greece, Hungary, Ireland, Israel, Italy, Lebanon, Netherlands, Norway, Poland, Portugal, Romania, Russian Federation, Slov... and more
-
Astellas Pharma Europe B.V.Completed
-
Genuine Research Center, EgyptHikma PharmaCompleted
-
Chang Gung Memorial HospitalUnknownOveractive Bladder Syndrome | Detrusor Overactivity
-
Ono Pharmaceutical Co. LtdCompleted
-
Astellas Pharma IncCompletedHealthy Volunteers | Pharmacokinetics of MirabegronFrance
-
National Taiwan University HospitalCompleted
-
Astellas Pharma Europe B.V.CompletedOveractive Bladder | Urgency Incontinence | Urinary Bladder Overactive | Urinary Bladder Diseases\Urologic DiseasesUnited States, Argentina, Australia, Belgium, Bulgaria, Canada, China, Colombia, Czechia, Denmark, Estonia, Finland, France, Germany, Greece, Hong Kong, Hungary, Italy, Korea, Republic of, Latvia, Lithuania, Malaysia, Mexico, Netherlands and more
-
Far Eastern Memorial HospitalRecruitingOveractive Bladder SyndromeTaiwan
-
Astellas Pharma IncCompletedOveractive BladderJapan
-
Buddhist Tzu Chi General HospitalUnknownOveractive Bladder SyndromeTaiwan
-
Bangabandhu Sheikh Mujib Medical University, Dhaka...CompletedOveractive BladderBangladesh
-
Astellas Pharma Europe B.V.CompletedOveractive Bladder | Urgency Incontinence | Urinary Bladder Overactive | Urinary Bladder Diseases\Urologic DiseasesBelgium, Russian Federation, Korea, Republic of, United States, Germany, Spain, Australia, Bulgaria, Canada, Czechia, Denmark, Estonia, Finland, Hungary, Italy, Latvia, Lithuania, Malaysia, Mexico, Netherlands, New Zealand, Norway, ... and more
-
China Medical University HospitalRecruitingSjogren's Syndrome | Overactive Bladder SyndromeTaiwan
-
Mansoura UniversityRecruitingUreteral Stent | Stent Related SymptomsEgypt
-
Far Eastern Memorial HospitalRecruitingOveractive Bladder SyndromeTaiwan
-
Astellas Pharma Europe B.V.CompletedHealthy Subjects | Pharmacokinetics | Drug-Drug Interaction (DDI)Germany
-
Mackay Memorial HospitalRecruitingUrinary Bladder, Overactive | Effect of Drug | UrodynamicsTaiwan
-
Astellas Pharma Europe B.V.CompletedHealthy Subjects | Pharmacokinetics | Drug-Drug Interaction (DDI)Germany
-
Astellas Pharma Europe B.V.CompletedUrologic Diseases | Urinary Bladder, Overactive | Urinary Bladder Diseases | Urological Manifestations | Signs and SymptomsBelarus, Belgium, Czechia, Denmark, Finland, France, Germany, Hungary, Italy, Netherlands, Norway, Poland, Portugal, Romania, Russian Federation, Slovakia, Spain, Sweden, Ukraine, United Kingdom
-
Samsung Medical CenterSamsung Biomedical Research InstituteCompletedOveractive BladderKorea, Republic of
-
Astellas Pharma Europe Ltd.CompletedUrologic Diseases | Urinary Bladder, Overactive | Urinary Bladder DiseasesGreece, Ireland, Armenia, Austria, Belarus, Belgium, Bulgaria, Canada, Czechia, Denmark, Finland, France, Georgia, Germany, Hungary, Italy, Kazakhstan, Latvia, Lebanon, Lithuania, Netherlands, Norway, Poland, Portugal, Russian Federation, Slovaki... and more
-
Astellas Pharma Europe B.V.CompletedPediatric | Neurogenic Detrusor OveractivityUnited States, Belgium, Korea, Republic of, Philippines, Poland, United Kingdom
-
Astellas Pharma Europe Ltd.CompletedOveractive Bladder (OAB) | Lower Urinary Tract Symptoms (LUTS)Ireland
-
The Affiliated Ganzhou Hospital of Nanchang UniversityActive, not recruiting
-
Astellas Pharma IncCompletedHealthy Volunteers | Pharmacokinetics of Solifenacin Succinate | Bioavailability of Solifenacin SuccinateUnited States
-
Hanmi Pharmaceutical Company LimitedCompleted
-
Astellas Pharma IncCompletedUrinary Bladder, OveractiveSweden, United Kingdom, Belgium, Denmark
-
Astellas Pharma Europe B.V.CompletedUrinary Bladder, OveractiveBelgium, United States, Brazil, Canada, Denmark, Former Serbia and Montenegro, Korea, Republic of, Mexico, Norway, Philippines, Poland, South Africa, Sweden, Turkey, Ukraine, United Kingdom
-
Center Eugene MarquisTerminated
-
Lahey ClinicAstellas Pharma US, Inc.TerminatedOveractive BladderUnited States
-
Astellas Pharma IncCompletedHealthy Subjects | Plasma Concentration of MirabegronJapan
-
National Taiwan University HospitalUnknownOveractive Bladder SyndromeTaiwan
-
Astellas Pharma IncCompletedHealthy Volunteers | Pharmacokinetics of Solifenacin SuccinateUnited States
-
Baylor Research InstituteThe Methodist Hospital Research Institute; International Urogynecological AssociationCompletedOveractive Bladder | Lower Urinary Tract Symptoms | Dementia | Incontinence, UrgeUnited States
-
Thomas Jefferson UniversityAstellas Pharma IncTerminatedAchalasiaUnited States
-
Astellas Pharma IncCompletedHealthy Subjects | Bioavailability | Pharmacokinetics of MirabegronNetherlands
-
Elsayed Abdelhalim ElsayedCompleted
-
KYU-SUNG LEEAstellas Pharma Korea, Inc.CompletedOveractive BladderKorea, Republic of
-
Loyola UniversityAstellas Pharma US, Inc.Completed
-
Astellas Pharma IncAstellas Pharma Korea, Inc.CompletedOver Active BladderKorea, Republic of
-
Seattle Urology Research CenterUnknownNocturia | Urinary Urgency | Urinary FrequencyUnited States
-
Cedars-Sinai Medical CenterRecruitingSyncope | Postural Orthostatic Tachycardia Syndrome | Chronic Orthostatic IntoleranceUnited States
-
Far Eastern Memorial HospitalRecruitingOveractive Bladder SyndromeTaiwan
-
Dong-A ST Co., Ltd.Active, not recruitingOveractive BladderKorea, Republic of
-
Loyola UniversityAstellas Pharma US, Inc.CompletedUrge Urinary IncontinenceUnited States